- Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab. Head & neck. 2016 In Process GET IT
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Annals of oncology : official journal of the European Society for Medical Oncology.
Times cited: 3
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. The Lancet Oncology. 2011 Report GET IT
- Guest Comment. Oncology Report. 2009 Information Resource
- A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?. Cancer Investigation. 2001 Editorial Article GET IT
Clinical economics of head and neck malignancies.
Hematology/oncology clinics of North America.
Times cited: 6